EU Vaccination Strategy
Europe’s digital future
Picture a medical emergency. A call to a first responder. The first moments of the call could mean the difference between life and death. What is the diagnosis? Is the patient in a critical condition? What if artificial intelligence could support the responder, helping them make the right…
EU COVID-19 Therapeutics Strategy
In combination with an increasing vaccination rate, better access to therapeutics means fewer hospitalisations, speedier recovery for COVID-19 patients and ultimately more lives saved. The EU strategy on COVID-19 therapeutics aims to support the development and increase the availability of…
EU COVID-19 certificate must facilitate free movement without discrimination
On Thursday, Parliament adopted its negotiating position on the proposal for a certificate to reaffirm the right to free movement in Europe during the pandemic. Universal, accessible, timely and free-of-charge testing needed across the EU EU COVID-19 certificates are not travel documents…
EU COVID-19 Certificate
The EU COVID-19 Certificate should facilitate safe free movement inside the EU during the COVID-19 pandemic. The Certificate will be a proof that a person has been vaccinated against COVID-19, received a negative test result or recovered from COVID-19. It will be available, free of charge,…
How do COVID-19 vaccines get to you?
How do COVID-19 vaccines get to you? Mass manufacturing of COVID-19 vaccines is complex and takes time. Up to 70% of manufacturing time is spent on testing and quality controls – ensuring doses are safe and effective. The European Commission is working with industry to step up manufacturing…
Health threats: boosting EU readiness and crisis management
The EU4Health programme aims to strengthen Europe’s health systems to better respond to future major international crises, such as the Covid-19 pandemic. The Covid-19 outbreak has shown the need for EU countries to better cooperate and coordinate in times of crisis and to…
Covid-19: the EU plan for the economic recovery
The EU is preparing massive investments to support people and businesses as Europe battles a deep economic recession due to the Covid-19 outbreak. On 27 May the European Commission presented in Parliament a €750 billion economic stimulus plan that along with a revised proposal for the…
How vaccines are approved in Europe by European Vaccination Information Portal
Only #vaccines that are safe and effective are approved for use in the European Union. How does the process of vaccine authorisation look like? Watch our video (turn on subtitles in your language) to learn more! Don’t forget to visit the European #Vaccination Information Portal…
The Digital Green Certificate
The European Union is introducing a Digital Green Certificate to remove obstacles to free movement within the EU. It is intended for each EU citizen who has received a COVID-19 vaccine, recovered from COVID-19 or had a negative test result. It is also open to family members if they come from…
How are vaccines developed, tested and authorised?
Vaccines are first studied in the laboratory. Developers determine their quality, safety and efficacy. Then, clinical trials are undertaken with human volunteers. These help confirm how vaccines work and how many doses are needed. Next, the vaccine developer submits the testing results to…
COVID-19 vaccination: MEPs call for EU and global solidarity
The EU must continue its concerted efforts to fight the COVID-19 pandemic and take urgent measures to ramp up vaccines production to meet citizens’ expectations, MEPs say. In the plenary debate on Wednesday with the Portuguese Presidency and Commission President Ursula von der Leyen, MEPs…
How are vaccines approved in the European Union?
Standard vaccine development is a long process and studies are done in sequential steps.The European Medicines Agency (EMA) plays an important role in enabling the development, scientific evaluation, approval and monitoring of COVID-19 vaccines in the European Union (EU). Vaccines for…
Safe Vaccines for Europeans
Following the recommendation of the European Medicines Agency, the European Commission has granted a conditional market authorisation for the first COVID-19 vaccine by BioNTech/Pfizer on December, 21st . TheCOVID-19 vaccines developed and authorised in the European Union are safe and…
MEPs demand more transparency on Covid-19 vaccines
Historical mass vaccination has started across the EU to curb the Covid-19 pandemic. In an unprecedented global approach, the European Commission is centralising vaccine contract negotiations and purchases for the bloc. Imagine the chaos if we had 27 different…
EU Vaccination Strategy
On 17 June, the European Commission presented a European vaccines strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. A safe and effective vaccine is our best bet to overcome the pandemic. Questions and answers on the EU…
Coronavirus: Commission unveils EU vaccines strategy
Today, to help protect people everywhere, the European Commission is presenting a European strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. An effective and safe vaccine against the virus is our best bet to achieve a permanent…
How mRNA vaccines protect you against COVID-19
Source: Council of the European Union, General Secretariat https://www.consilium.europa.eu/en/infographics/covid-19-mrna-vaccine/
